2026 NPPES data Neurology Physician NPI 1265434443 M.D.
Verify on CMS →

SCOTT GOODMAN, M.D.

Neurology Physician in OMAHA, Nebraska. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 302 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$22.3K
319 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SCOTT GOODMAN, M.D. is a Neurology Physician ([object Object]) practicing in OMAHA, Nebraska with a Medicare Part D prescribing footprint of 2K claims across 302 beneficiaries — 17% brand-name prescribing . Industry payments of $22.3K across 319 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SCOTT GOODMAN, M.D. filed 2,459 Medicare Part D claims in 2023 across OMAHA, Nebraska. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SCOTT GOODMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SCOTT GOODMAN, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 06/01/2005

NPI 1265434443

Primary specialty

Neurology Physician

Mid-sized

19,866 US NPIs in this specialty

Medicare Part D claims

2,459 88% vs specialty avg

2023 prescription claims

Specialty avg: 1,309

Specialty distribution in Nebraska

How Neurology Physician compares to other specialties among Nebraska providers

Nebraska providers

Neurology Physician share within Nebraska

1. Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neurology Physician share within Nebraska

Specialty board-certification context

Estimated specialty board-certified rate — Neurology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neurology Physician ABMS/AOA estimate

Est. board-certified rate (Neurology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neurology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SCOTT GOODMAN, M.D. is a Neurology Physician provider practicing in OMAHA, Nebraska, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1265434443. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SCOTT GOODMAN, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 4242 FARNAM ST, OMAHA, NE, 68131, with a listed phone of (402) 552-2650. NPI 1265434443 was issued on 06/01/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GOODMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,459 prescription claims written by this provider, covering 302 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4242 FARNAM ST
OMAHA, NE 68131

Provider Details

NPI 1265434443
Specialty Neurology Physician
Credentials M.D.
Gender Male
NPI Issued 06/01/2005

Hospital and facility affiliations

Facilities where SCOTT GOODMAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NEUROLOGY CONSULTANTS OF NEBRASKA PC
PAPILLION, NE

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SCOTT GOODMAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$22.3K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

SCOTT GOODMAN, M.D. — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 2,459 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,459
Total Claims
$1.1M
Total Drug Cost
302
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,512
Total Day Supply
99,802
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$946K
Generic Drug Cost
$120K
Opioid Claims
23 (0.9% rate)

Patient Demographics

Average Patient Age
65.5 years
Avg HCC Risk Score
1.25
Gender Split
68% female / 32% male
Age Distribution
<65: 107, 65-74: 112, 75-84: 63, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Topiramate
187
Carbidopa-Levodopa
Carbidopa/Levodopa
147
Gabapentin
145
Levetiracetam
110
Primidone
104
Emgality Pen
Galcanezumab-Gnlm
83
Divalproex Sodium Er
Divalproex Sodium
72
Sumatriptan Succinate
69
Amitriptyline Hcl
60
Carbidopa-Levodopa Er
Carbidopa/Levodopa
57

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How SCOTT GOODMAN, M.D. fits within the Neurology Physician landscape nationally.

19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider

SCOTT GOODMAN, M.D.'s 2,459 claims are above the specialty average of 1,309.

Nearby Neurology Physician Providers in Nebraska

Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as GOODMAN.

Compare Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SCOTT GOODMAN, M.D.'s specialty?
SCOTT GOODMAN, M.D. specializes in Neurology Physician and practices in OMAHA, Nebraska. Credentials: M.D..
How much does SCOTT GOODMAN, M.D. prescribe under Medicare Part D?
In 2023, SCOTT GOODMAN, M.D. wrote 2,459 Medicare Part D claims totaling $1.1M in drug costs for 302 beneficiaries.
Where is SCOTT GOODMAN, M.D. located?
SCOTT GOODMAN, M.D. is located at 4242 FARNAM ST, OMAHA, NE, 68131. Phone: (402) 552-2650.
What is SCOTT GOODMAN, M.D.'s NPI number?
SCOTT GOODMAN, M.D.'s National Provider Identifier (NPI) is 1265434443, issued on 06/01/2005.
Does SCOTT GOODMAN, M.D. prescribe more brand-name or generic drugs?
SCOTT GOODMAN, M.D.'s prescribing is 17% brand-name and 83% generic drugs by claim count, with $946K in brand drug costs.
Does SCOTT GOODMAN, M.D. prescribe opioids?
Yes, SCOTT GOODMAN, M.D. had 23 opioid claims in 2023 with an opioid prescribing rate of 0.9%.
How many Neurology Physician providers are there in the US?
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does SCOTT GOODMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SCOTT GOODMAN, M.D.'s most frequently prescribed drugs include Topiramate, Carbidopa-Levodopa, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SCOTT GOODMAN, M.D. accept Medicare?
SCOTT GOODMAN, M.D. appears in CMS Medicare data with 2,459 Part D claims and 302 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SCOTT GOODMAN, M.D.'s credentials?
SCOTT GOODMAN, M.D.'s NPI is 1265434443 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology